SNDL Inc.
NASDAQ:SNDLDrug Manufacturers - Specialty & Generic
-$0.03 today
- Market cap
- $326.64M
- Beta
- 0.91
- P/E (TTM)
- -47.4
- EPS (TTM)
- -$0.04
Volume 1.00M
Average 2.21M
SNDL Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
SNDL Inc.NASDAQ: SNDL
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development declines year over year
Q1 FY2026 research & development of CA$4K fell 96.0% year over year, behind the -3.9% change in trailing-twelve-month research & development. Sequentially, it fell 97.0% from the prior quarter. Over 3 fiscal years it compounded at -41.5% a year.
Context
- Research & development amounted to 0.1% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -96.0% toward the trailing-twelve-month pace of -3.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
CAD · from the income statement
- Latest · FY2025
- 489K CAD
- Year-over-year change
- +41.3%
- 4-year CAGR
- -33.1%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 489K | +41.3% |
| FY2024 | 2024-12-31 | 346K | +6.8% |
| FY2023 | 2023-12-31 | 324K | -86.8% |
| FY2022 | 2022-12-31 | 2.45M | +0.1% |
| FY2021 | 2021-12-31 | 2.45M | — |
Research & Development vs competitors
How SNDL compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -3.9% is the 8th highest of 11, against a peer median of +2.6%.
- Research & development amounts to 0.0% of revenue for SNDL, versus a peer median of 10.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $2.7T USD | +25130615.4% | -33.8% | 2884018.5% | |
| LTM Mar 2026 | $176.31M USD | +40.8% | +24.2% | — | |
| LTM Mar 2026 | $110.07M USD | -12.0% | +22.1% | — | |
| LTM Mar 2026 | $67.09M USD | +78.1% | -27.8% | 28.9% | |
| LTM Mar 2026 | $49.1M USD | -30.6% | -34.1% | 7.3% | |
| LTM Mar 2026 | $49.06M USD | +2.0% | +3.9% | 9.6% | |
| LTM Mar 2026 | $44.28M USD | -2.4% | -26.2% | 10.6% | |
| LTM Mar 2026 | $37.44M USD | +64.5% | +11.3% | — | |
| LTM Mar 2026 | $16.04M USD | -18.6% | -0.6% | 31.9% | |
| LTM Mar 2026 | $9.6M USD | +3.2% | +12.4% | 3.2% | |
| LTM Mar 2026 | CA$393K CAD | -3.9% | -41.5% | 0.0% | |
| Peer median (excluding SNDL) | — | +2.6% | +1.7% | 10.6% | |
Competitors are the stored peer set for SNDL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 56.13M | 712.2M | 909.01M | 920.45M | 946.4M |
| Cost of Revenue | 65.13M | 571.82M | 718.59M | 680.12M | 687.75M |
| Gross Profit | (9M) | 140.38M | 190.42M | 240.33M | 258.65M |
| Gross Margin | -16.0% | 19.7% | 20.9% | 26.1% | 27.3% |
| Research & Development | 2.45M | 2.45M | 324K | 346K | 489K |
| Selling, General & Admin | 55.39M | 158.26M | 230.17M | 219.28M | 210.63M |
| Operating Expenses | 125.38M | 488.15M | 353.59M | 344.14M | 263.07M |
| Depreciation & Amortization | 10.16M | 47.32M | 64.95M | 56.71M | 56.27M |
| EBITDA | (223.76M) | (326.55M) | (99.15M) | (41.2M) | 48.02M |
| EBITDA Margin | -398.7% | -45.9% | -10.9% | -4.5% | 5.1% |
| Operating Income | (134.38M) | (347.77M) | (163.17M) | (103.81M) | (4.42M) |
| Operating Margin | -239.4% | -48.8% | -18.0% | -11.3% | -0.5% |
| Interest Income | 13.72M | 17.62M | 15.37M | 16.4M | 8.05M |
| Interest Expense | 776K | 5.9M | 7.92M | 7.7M | 7.52M |
| Other Income / Expenses | (100.32M) | (32M) | (8.85M) | (1.8M) | (11.35M) |
| Income Before Tax | (234.7M) | (379.77M) | (172.02M) | (105.61M) | (15.77M) |
| Pre-Tax Margin | -418.1% | -53.3% | -18.9% | -11.5% | -1.7% |
| Income Tax Expense | (7.91M) | (7.34M) | 0 | (9.41M) | 0 |
| Net Income | (226.98M) | (335.11M) | (172.66M) | (94.8M) | (15.77M) |
| Net Margin | -404.4% | -47.1% | -19.0% | -10.3% | -1.7% |
| EPS (Basic) | (1.24) | (1.50) | (0.65) | (0.38) | (0.06) |
| EPS (Diluted) | (1.24) | (1.50) | (0.65) | (0.38) | (0.06) |
| Weighted Avg Shares | 186.04M | 229.87M | 259.37M | 264.2M | 258.05M |
| Weighted Avg Shares (Diluted) | 186.04M | 229.87M | 259.37M | 264.2M | 258.05M |
SNDL Inc.
NASDAQ:SNDL
Intrinsic Alpha fair value
Locked
Current Price
$1.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.